Clinical Professor, Infectious Disease, Baylor College of Medicine
Infectious Disease
Dr. Herbert L. Dupont, MD
|
|
Give Review
Doctor Herbert L. Dupont, MD works in the field of Infectious Disease. He graduated from Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. He over the years received 5 awards: "America's Top Doctors", "Top Doctors:SE Texas", "Elected Member", "Super Doctor" and "Top MD". Doctor Herbert L. Dupont, MD is a published doctor. He has 101 papers published. The most current publication "Characterization of the human gut microbiome during travelers' diarrhea."
Publications
- Loperamide Therapy for Voluminous Diarrhea in Ebola Virus Disease.
- Characterization of the human gut microbiome during travelers' diarrhea.
- Traveler's diarrhea: a clinical review.
- Targeting of Rifamycin SV to the Colon for Treatment of Travelers' Diarrhea: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
- A Hospital-based Study of the Clinical Characteristics of Clostridium difficile Infection in Children.
- Challenges and opportunities in the management of Clostridium difficile infection.
- Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile-Associated Disease Rates.
- Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
- Chemoprophylaxis of Clostridium difficile Infections in High-Risk Hospitalized Patients.
- Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-c...
- Persistent Abdominal Symptoms in US Adults After Short-Term Stay in Mexico.
- Motility Abnormalities in Irritable Bowel Syndrome.
- Colonic Immunopathogenesis of Clostridium difficile Infections.
- Seroepidemiology of norovirus-associated travelers' diarrhea.
- Development and Accuracy of Quantitative Real-Time Polymerase Chain Reaction Assays for Detection and Quantification of Enterotoxigenic Escherichia coli (ETEC) Heat La...
- Chronic complications after travelers' diarrhea.
- Use of Rifamycin Drugs and the Development of Infection by Rifamycin-Resistant Strains of Clostridium difficile.
- Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination.
- Diagnosis and Management Clostridium difficile Infection.
- Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-?-N...
- Multidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohn's Disease.
- Physician Attitudes Towards the Use of Fecal Transplantation for Recurrent Clostridium Difficile Infection in a Large Metropolitan City.
- Clostridium difficile: an emerging pathogen in children.
- Intestinal decontamination inhibits TLR4 dependent fibronectin mediated crosstalk between stellate cells and endothelial cells in liver fibrosis in mice.
- Approach to the patient with infectious colitis.
- A NOVEL ONE-STEP METHOD FOR DETECTION AND ISOLATION OF ACTIVE TOXIN-PRODUCING CLOSTRIDIUM DIFFICILE STRAINS DIRECTLY FROM STOOL SAMPLES.
- A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile inf...
- Moderate to High Use of Opioid Analgesics Are Associated With an Increased Risk of Clostridium difficile Infection.
- A Randomized, Double-Blind, Pilot Study of Rifaximin 550 mg Versus Placebo in the Prevention of Travelers' Diarrhea in Mexico During the Dry Season.
- Unraveling the Role of Host Endocytic Proteins in Pedestal Formation During Enteropathogenic Escherichia coli Infection.
- The intestinal microbiota and chronic disorders of the gut.
- Gastrointestinal infections and the development of irritable bowel syndrome.
- Advances in the Treatment of Travelers' Diarrhea.
- Harnessing The Glucosyltransferase Activities of Clostridium difficile For Functional Studies of Toxins A and B.
- Single Nucleotide Polymorphisms in the Promoter of the Gene Encoding the Lipopolysaccharide Receptor CD14 Are Associated With Bacterial Diarrhea in US and Canadian Tra...
- Vitamin a modifies the intestinal chemokine and cytokine responses to norovirus infection in mexican children.
- Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico.
- Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections.
- The search for effective treatment of Clostridium difficile infection.
- New Developments in Traveler's Diarrhea.
- In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.
- Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.
- Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques.
- A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.
- Bile acids improve the antimicrobial effect of rifaximin.
- Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance.
- Noroviruses: The leading cause of gastroenteritis worldwide.
- Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007.
- Pulsed-field gel electrophoresis for Salmonella infection surveillance, Texas, USA, 2007.
- Traveling internationally: avoiding and treating travelers' diarrhea.
- Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.
- Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.
- Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species.
- Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections.
- Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
- Travel and travelers' diarrhea in patients with irritable bowel syndrome.
- Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies.
- Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
- Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles.
- Clinical practice. Bacterial diarrhea.
- Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients.
- A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection.
- Global etiology of travelers' diarrhea: systematic review from 1973 to the present.
- Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas.
- Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis.
- WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas.
- A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia co...
- Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested.
- Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study.
- Association of diarrheagenic Escherichia coli Pathotypes with infection and diarrhea among Mexican children and association of atypical Enteropathogenic E. coli with a...
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.
- The controversial and short-lived early use of rehydration therapy for cholera.
- New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
- Peripartum Clostridium difficile infection: case series and review of the literature.
- Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the Un...
- Epidemiology of cryptosporidiosis in North American travelers to Mexico.
- Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas.
- Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
- PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea.
- Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
- President's address: travel medicine and principles of safe travel.
- The growing threat of foodborne bacterial enteropathogens of animal origin.
- Epidemiology of Clostridium difficile-associated diarrhea in a Peruvian tertiary care hospital.
- Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children.
- Vitamin A supplementation has divergent effects on norovirus infections and clinical symptoms among Mexican children.
- Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
- Therapy for and prevention of traveler's diarrhea.
- Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
- A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico.
- Relearning the importance of disease prevention among international travelers.
- Azithromycin for the self-treatment of traveler's diarrhea.
- Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries.
- Risk factors associated with diarrhea among international visitors to Cuzco, Peru.
- Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico.
- Vitamin A supplementation reduces the monocyte chemoattractant protein-1 intestinal immune response of Mexican children.
- Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis.
- Nitazoxanide for the treatment of Clostridium difficile colitis.
- Asymptomatic norovirus infection in Mexican children.
- Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses.
- New insights and directions in travelers' diarrhea.
Schools
Emory University
University Minn Hosps
University MD
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- Elected Member
- Super Doctor
- Top MD
Education
-
University of Maryland -
University of Minnesota at Fairview -
Emory University School of Medicine
Hospital
-
Baylor St. Luke's Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Gopikishan R. Rangaraj, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dipti Agrawal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Tweardy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin A. Grimes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shahe E. Vartivarian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ella J. Ariza-Heredia, MD
This Doctor is OpenDoctor Recommended.
|